NextGen Healthcare Fully Prevails in Hussein Trial Jury Verdict

7/30/2021

Trial Completed; NextGen Healthcare Confirms No Liability and No Change to Q1FY22 Financial Results

ATLANTA--(BUSINESS WIRE)--Jul. 30, 2021-- NextGen Healthcare, Inc.(Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, announced that the Ahmed D. Hussein v. Sheldon Razin, Steven Plochockiand Quality Systems, Inc.lawsuit filed in the Superior Court of the State of Californiafor the County of Orangeon October 7, 2013concluded on July 29, 2021with a jury verdict in favor of the Company and Messrs. Razin and Plochocki on all counts with no financial liability for the Company. As such, no adjustments are necessary to the Company’s Q1FY22 financials, which were reported on July 29, 2021, just over an hour before the jury returned its verdict. The Company will file its Quarterly Report on Form 10-Q today on Friday, July 30, 2021.

Safe Harbor Provision

Please refer to the Q1F22 earnings release dated July 29, 2021for Safe Harbor Provisions and Forward-Looking Statement.

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc.(Nasdaq: NXGN) is a leading provider of ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral, and dental providers in their journey to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better. Learn more atwww.orderpulsa.com, and follow us onFacebook,Twitter,LinkedIn,YouTubeandInstagram.

Investor Relations Contact
Matthew Scalo
(415) 370-9202
mscalo@www.orderpulsa.com

Source: NextGen Healthcare, Inc.